Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Kerr

Showing results (101-110 of 221) with videos related to

Pageof 23
Sort By:
Biochemical Pharmacology|June 29, 1995
Induction of the c-myc but not the cH-ras promoter by platinum compoundsA G Eliopoulos, D J Kerr, H R Maurer, et al.
Cancer|October 15, 1991
Successful use of cisplatin to treat metastatic seminoma during cisplatin-induced acute renal failureJ G Fox, D J Kerr, M Soukop, et al.
The British Journal of Surgery|February 1, 1988
Cytotoxic-loaded albumin microspheres: a novel approach to regional chemotherapyC S McArdle, H Lewi, D Hansell, et al.
The Journal of Biological Chemistry|October 27, 1995
Wortmannin and its structural analogue demethoxyviridin inhibit stimulated phospholipase A2 activity in Swiss 3T3 cells. Wortmannin is not a specific inhibitor of phosphatidylinositol 3-kinaseM J Cross, A Stewart, M N Hodgkin, et al.
Chronobiologia|July 1, 1986
Chronobiologic quantification of nocturnal low-dose dopamine effect on circadian rhythms of thyroid-related hormones and prolactin (PRL)D J Kerr, V K Singh, W D Alexander, et al.
British Journal of Cancer|December 1, 1991
Phase I and pharmacokinetic study of D-verapamil and doxorubicinD Bissett, D J Kerr, J Cassidy, et al.
British Journal of Cancer|January 1, 1992
A pharmacokinetic comparison of intravenous versus intra-arterial folinic acidJ H Anderson, D J Kerr, A Setanoians, et al.
Neurosurgery|March 1, 1995
Hemangioblastoma of the optic nerve: case reportD J Kerr, B W Scheithauer, G M Miller, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1987
Generalised peripheral nerve dysfunction in acromegaly: a study by conventional and novel neurophysiological techniquesG A Jamal, D J Kerr, A R McLellan, et al.
Gene Therapy|April 1, 2005
Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapyD H Palmer, M-J Chen, P F Searle, et al.
Pageof 23

Showing results (101-110 of 221) with videos related to

Sort By:
Pageof 23
Biochemical Pharmacology|June 29, 1995
Induction of the c-myc but not the cH-ras promoter by platinum compoundsA G Eliopoulos, D J Kerr, H R Maurer, et al.
Cancer|October 15, 1991
Successful use of cisplatin to treat metastatic seminoma during cisplatin-induced acute renal failureJ G Fox, D J Kerr, M Soukop, et al.
The British Journal of Surgery|February 1, 1988
Cytotoxic-loaded albumin microspheres: a novel approach to regional chemotherapyC S McArdle, H Lewi, D Hansell, et al.
The Journal of Biological Chemistry|October 27, 1995
Wortmannin and its structural analogue demethoxyviridin inhibit stimulated phospholipase A2 activity in Swiss 3T3 cells. Wortmannin is not a specific inhibitor of phosphatidylinositol 3-kinaseM J Cross, A Stewart, M N Hodgkin, et al.
Chronobiologia|July 1, 1986
Chronobiologic quantification of nocturnal low-dose dopamine effect on circadian rhythms of thyroid-related hormones and prolactin (PRL)D J Kerr, V K Singh, W D Alexander, et al.
British Journal of Cancer|December 1, 1991
Phase I and pharmacokinetic study of D-verapamil and doxorubicinD Bissett, D J Kerr, J Cassidy, et al.
British Journal of Cancer|January 1, 1992
A pharmacokinetic comparison of intravenous versus intra-arterial folinic acidJ H Anderson, D J Kerr, A Setanoians, et al.
Neurosurgery|March 1, 1995
Hemangioblastoma of the optic nerve: case reportD J Kerr, B W Scheithauer, G M Miller, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1987
Generalised peripheral nerve dysfunction in acromegaly: a study by conventional and novel neurophysiological techniquesG A Jamal, D J Kerr, A R McLellan, et al.
Gene Therapy|April 1, 2005
Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapyD H Palmer, M-J Chen, P F Searle, et al.
Pageof 23